# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-25-092569
Filing Date
2025-09-23
Accepted
2025-09-23 17:14:23
Documents
7
Period of Report
2025-11-17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | pmn-20251117xpre14a.htm | PRE 14A | 286661
2 | GRAPHIC | pmn-20251117xpre14a_a003.jpg | GRAPHIC | 15980
3 | GRAPHIC | pmn-20251117xpre14a_bg001.jpg | GRAPHIC | 183190
4 | GRAPHIC | pmn-20251117xpre14a_bg002.jpg | GRAPHIC | 146710
5 | GRAPHIC | pmn-20251117xpre14a_bg003.jpg | GRAPHIC | 24689
6 | GRAPHIC | pmn-20251117xpre14a_cg001.jpg | GRAPHIC | 120195
7 | GRAPHIC | pmn-20251117xpre14a_cg002.jpg | GRAPHIC | 142364
| Complete submission text file | 0001104659-25-092569.txt |  | 1146523

Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41429 | Film No.: 251334545
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)